CC BY 4.0 · Rev Bras Ginecol Obstet 2022; 44(06): 573-577
DOI: 10.1055/s-0042-1746199
Original Article
Gynecological Endocrinology

Practical Prediction Model for Ovarian Insufficiency after Radiation

Modelo prático de predição para insuficiência ovariana após radiação
1   Radiotherapy Department, Hospital Mater Dei, Belo Horizonte, MG, Brazil
2   Gynecology Department, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Botucatu, SP, Brazil
,
1   Radiotherapy Department, Hospital Mater Dei, Belo Horizonte, MG, Brazil
,
2   Gynecology Department, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Botucatu, SP, Brazil
3   Oncology Department, Grupo Oncoclínicas, Belo Horizonte, MG, Brazil
,
1   Radiotherapy Department, Hospital Mater Dei, Belo Horizonte, MG, Brazil
,
4   Gynecology Department, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
,
5   Radiotherapy Department, Hospital da Baleia, Belo Horizonte, MG, Brazil
,
5   Radiotherapy Department, Hospital da Baleia, Belo Horizonte, MG, Brazil
,
5   Radiotherapy Department, Hospital da Baleia, Belo Horizonte, MG, Brazil
,
6   Faculty of Medicine, Faculdade de Minas, Belo Horizonte, MG, Brazil
,
2   Gynecology Department, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Botucatu, SP, Brazil
3   Oncology Department, Grupo Oncoclínicas, Belo Horizonte, MG, Brazil
› Author Affiliations

Abstract

Objective The present study aimed to develop a useful mathematical model that predicts the age at which premature ovarian insufficiency might occur after teletherapy radiation. A diagnosis of premature or early menopause has physical and psychological consequences, so women may need support and long-term medical follow-up.

Methods To correlate ovarian radiation dose with ovarian function, we used the formula described by Wallace et al.: √g(z) = 10(2-0,15z), where “g(z)” and “z” represent oocyte survival rate and the radiation dose (in Gray), respectively. By simulating different ages and doses, we observed a pattern that could be used to simplify the relationship between radiation dose and remaining time of ovarian function.

Results We obtained a linear function between ovarian radiation dose and loss of ovarian function (LOF) that is the percentage of decrease in the time to the ovarian failure compared with the time expected for a woman at the same age without irradiation exposition. For patients < 40 years old and with ovarian radiation doses < 5 Gy, the equation LOF = 2.70 + (11.08 x Dose) can be applied to estimate the decrease in time to premature ovarian insufficiency.

Conclusion The present study reports a practicable theoretical method to estimate the loss of ovarian function. These findings can potentially improve the management and counseling of young women patients submitted to radiotherapy during their reproductive years.

Resumo

Objetivo O presente estudo teve como objetivo desenvolver um modelo matemático útil que prediz a idade na qual a insuficiência ovariana prematura pode ocorrer após a radioterapia externa (teleterapia). O diagnóstico de menopausa prematura ou precoce tem consequências físicas e psicológicas; portanto, as mulheres podem precisar de apoio e acompanhamento médico de longo prazo.

Métodos Para correlacionar a dose de radiação ovariana com a função ovariana, foi usada a fórmula descrita por Wallace et al.: √g(z) = 10(2-0,15z), na qual “g(z)” e “z” representam a taxa de sobrevivência do oócito e a dose de radiação (em Gray), respectivamente. Ao simular diferentes idades e doses, observamos um padrão que poderia ser usado para simplificar a relação entre a dose de radiação e o tempo restante da função ovariana.

Resultados Obtivemos uma função linear entre a dose de radiação ovariana e a perda da função ovariana (LOF, na sigla em inglês) que é a porcentagem de diminuição no tempo até a falência ovariana em relação ao tempo esperado para uma mulher da mesma idade sem exposição à radiação. Para pacientes < 40 anos de idade e com doses de radiação ovariana < 5 Gy, a equação LOF = 2,70 + (11,08 x Dose) pode ser aplicada para estimar a redução no tempo até a insuficiência ovariana.

Conclusão O presente estudo relata um método teórico viável para estimar a perda da função ovariana. Estes achados podem melhorar potencialmente o manejo e o aconselhamento de pacientes jovens submetidas à radioterapia durante seus anos reprodutivos.



Publication History

Received: 25 April 2021

Accepted: 14 February 2022

Article published online:
26 May 2022

© 2022. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Silva-Filho AL, Carmo GA, Athayde GR, Assis ME, Almeida RC, Leal RHS. et al. Safe fertility-preserving management in gynecological malignancies. Arch Gynecol Obstet 2007; 275 (05) 321-330
  • 2 Rodriguez-Wallberg KA, Oktay K. Options on fertility preservation in female cancer patients. Cancer Treat Rev 2012; 38 (05) 354-361
  • 3 Loren AW, Mangu PB, Beck LN, Brennan L, Magdakinski AJ, Partridge AH. et al; American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31 (19) 2500-2510
  • 4 Oktem O, Kim SS, Selek U, Schatmann G, Urman B. Ovarian and uterine functions in female survivors of childhood cancers. Oncologist 2018; 23 (02) 214-224
  • 5 Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986; 67 (04) 604-606
  • 6 Suhag V, Sunita BS, Sarin A, Singh AK, Dashottar S. Fertility preservation in young patients with cancer. South Asian J Cancer 2015; 4 (03) 134-139
  • 7 Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J. et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004; 22 (05) 872-880
  • 8 Wallace WH, Shalet SM, Hendry JH, Morris-Jones PH, Gattamaneni HR. Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte. Br J Radiol 1989; 62 (743) 995-998
  • 9 Terenziani M, Piva L, Meazza C, Gandola L, Cefalo G, Merola M. Oophoropexy: a relevant role in preservation of ovarian function after pelvic irradiation. Fertil Steril 2009; 91 (03) 935.e15-935.e16
  • 10 Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod 2003; 18 (01) 117-121
  • 11 Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One 2010; 5 (01) e8772
  • 12 Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y. et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 2006; 91 (05) 1723-1728
  • 13 Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005; 62 (03) 738-744
  • 14 The MathWorks. MATLAB and statistics toolbox release. Natick: MathWorks; 2012
  • 15 Wallace WH, Kelsey TW. Ovarian reserve and reproductive age may be determined from 10.1093/humrep/deh285
  • 16 Montgomery DC, Peck EA, Vining GG. Introduction to linear regression analysis. 5th ed.. Hoboken: Wiley; 2012
  • 17 Qiao L, Cheng J, Liang N, Xie J, Luo H, Zhang J. A comparative dosimetric study of volumetric-modulated arc therapy vs. fixed field intensity-modulated radiotherapy in postoperative irradiation of stage IB-IIA high-risk cervical cancer. Oncol Lett 2016; 11 (02) 959-964
  • 18 Hodel K, Rich WM, Austin P, DiSaia PJ. The role of ovarian transposition in conservation of ovarian function in radical hysterectomy followed by pelvic radiation. Gynecol Oncol 1982; 13 (02) 195-202
  • 19 Feeney DD, Moore DH, Look KY, Stehman FB, Sutton GP. The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol 1995; 56 (01) 3-7
  • 20 Anderson B, LaPolla J, Turner D, Chapman G, Buller R. Ovarian transposition in cervical cancer. Gynecol Oncol 1993; 49 (02) 206-214
  • 21 Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987; 65 (06) 1231-1237
  • 22 Gougeon A, Chainy GB. Morphometric studies of small follicles in ovaries of women at different ages. J Reprod Fertil 1987; 81 (02) 433-442
  • 23 Ghadjar P, Budach V, Köhler C, Jantke A, Marnitz S. Modern radiation therapy and potential fertility preservation strategies in patients with cervical cancer undergoing chemoradiation. Radiat Oncol 2015; 10: 50